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Abstract
Motivation: Human proteins that are secreted into different body fluids from various cells and tissues can be promising disease indicators. Modern proteomics research empowered by both qualitative and quantitative profiling techniques has made great progress in protein discovery in various human fluids. However, due to the large number of
proteins and diverse modifications present in the fluids, as well as the existing technical limits of major proteomics
platforms (e.g. mass spectrometry), large discrepancies are often generated from different experimental studies. As
a result, a comprehensive proteomics landscape across major human fluids are not well determined.
Results: To bridge this gap, we have developed a deep learning framework, named DeepSec, to identify secreted
proteins in 12 types of human body fluids. DeepSec adopts an end-to-end sequence-based approach, where a
Convolutional Neural Network is built to learn the abstract sequence features followed by a Bidirectional Gated
Recurrent Unit with fully connected layer for protein classification. DeepSec has demonstrated promising performances with average area under the ROC curves of 0.85–0.94 on testing datasets in each type of fluids, which outperforms existing state-of-the-art methods available mostly on blood proteins. As an illustration of how to apply
DeepSec in biomarker discovery research, we conducted a case study on kidney cancer by using genomics data
from the cancer genome atlas and have identified 104 possible marker proteins.
Availability: DeepSec is available at https://bmbl.bmi.osumc.edu/deepsec/.
Contact: wy6868@jlu.edu.cn or jcui@unl.edu
Supplementary information: Supplementary data are available at Bioinformatics online.

1 Introduction
Human body fluids, such as blood, saliva and urine, are primary
clinical specimens, which hold considerable promises in presenting
molecular biomarkers for disease diagnosis and therapeutic monitoring (Anderson, 2010; Lathrop et al., 2003). Since the first study of
serum globulin was reported in 1937 (Tiselius, 1937), several largescale research efforts have been made to profile proteomes in various
types of human body fluids, mostly in blood, using different proteomic technologies, such as two-dimensional gel electrophoresis
(Margolis and Kenrick, 1969), mass spectrometry (Thomson, 1914)
and liquid chromatography (Zhao and Lin, 2014). As a result, a
large number of protein species were identified in different body
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fluids, which have been documented in a large volume of research
papers and archived in several community-based proteomic databases such as Human Plasma Proteome Project (Legrain et al.,
2011), Plasma Proteome Database (Nanjappa et al., 2014) and
Human Plasma PeptideAtlas (Schwenk et al., 2017).
Due to the large complexity of protein content and postmodifications involved in different body fluids, protein identification
using conventional proteomics techniques remains a challenging research topic in the past decade. To facilitate this research, several
computational attempts have been made to predict secreted proteins
in human body fluids, mostly based on machine learning methods,
such as Support Vector Machine (SVM) (Cui et al., 2008; Hong
et al., 2011; Sun et al., 2015; Wang et al., 2013, 2016b). These models often used common protein features such as amino acid flexibility
228
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DeepSec
index, surface tension and solubility as input and predict secreted
proteins associated with a specific body fluid. Although the performances of those methods were promising, featured-based models generally suffered from common limitations such as the blind manual
collection of features that might be incomplete and biased and feature selection procedures that need manual intervention. To this
end, automatic feature extraction using end-to-end model can dispense with the initial feature selection step and possibly improve the
prediction performance.
Deep learning (DL) has been successfully applied in protein research to study new protein functions, structures and interactions
(Jain et al., 2021). Among different DL models, Convolutional
Neural Network (CNN) has been one of the most frequently used
methods and has attained remarkable performances in several classification applications, especially when combined with Gated
Recurrent Unit (GRU) (Wilaiprasitporn et al., 2020). GRU, as a new
class of Recurrent Neural Networks (RNNs), can effectviely solve
the vanishing gradient problem by introducing memory cells and a
gating mechanism for holding information from the prior inputs in a
well-behaved way. Compared to Long Short-Term Memory, GRU
has a relatively simple structure, which ensures reduced complexity
and faster convergence. Recent successes with GRU on the basis of
protein sequences include DeepSig (a model to detect signal peptides
of proteins) (Savojardo et al., 2018) and DeepLoc (a model for predicting protein subcellular localization) (Armenteros et al., 2017).
The high performances from both studies indicate that protein
sequences must carry important characteristics related to protein
sorting.
In this study, we present a new DL-framework, named DeepSec,
to facilitate body-fluid secreted protein prediction. DeepSec adopts
an end-to-end sequence-based approach and employs CNN as a feature extractor and Bidirectional Gated Recurrent Unit (BGRU) with
fully connected dense layer as a classifier to predict secreted proteins.
We have employed DeepSec on 12 different types of common human
body fluids (one model for each body fluid), which include blood,
saliva, urine, cerebrospinal fluid, seminal fluid, amniotic fluid, tear
fluid, bronchoalveolar lavage fluid, milk, nipple aspirate fluid, pleural effusion and sputum. At last, we demonstrate possible applications of DeepSec in biomarker discovery by a kidney cancer case
study.

2 Materials and methods
2.1 Datasets
The positive datasets of DeepSec were collected from our previous
work (Huang et al., 2021). For negative dataset generation, we
employed a similar method that is proposed by Cui et al. (2008),
where the Pfam family annotation was used to select proteins that
are potential non-body-fluid-secretory proteins. We chose negative
samples from Pfam families (Pfam release 33.1) (Sara et al., 2018)
which do not contain any proteins in the positive dataset. According
to the size of the positive dataset varies in different fluid type, the selection of negative samples is carried out as follows. For a specific
body fluid, if the count of positive-related Pfam families is greater
than 30% of the total number of human-related Pfam families, all
proteins in the remaining Pfam families were collected as the negative set. In contrast, if the count is <30%, we randomly chose one
member from each remaining Pfam families to construct the negative
data.
Using the above procedure, we have collected both positive and
negative datasets for each of the 12 body fluids (Fig. 1), including
8203 and 2739 proteins in blood, 4072 and 3291 proteins in saliva,
8048 and 5136 proteins in urine, 6260 and 5787 proteins in cerebrospinal fluid, 5576 and 2624 proteins in seminal fluid, 3212 and
3722 proteins in amniotic fluid, 1490 and 4184 proteins in tear
fluid, 1117 and 4436 proteins in bronchoalveolar lavage fluid, 2171
and 3887 proteins in milk, 2234 and 4009 proteins in nipple aspirate
fluid, 1373 and 4328 proteins in pleural effusion, and 2341 and
3967 proteins in sputum.
Training DL models generally benefits from datasets with a balanced size. To address the imbalance problem, a random under-
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Fig. 1. The distribution of 12 types of body fluids that are analyzed in this study

sampling process is adopted in this study, which is advantageous
over the procedure of eliminating proteins from the over-sized larger
dataset to match the size of smaller dataset that may lead to information loss. We randomly partitioned the larger dataset into smaller
subsets with similar size of the smaller dataset. For a size ratio t between the positive and negative datasets, roundðtÞ subsets are created randomly. Each generated new subset and the original smaller
dataset are resampled together to generate independent datasets for
model evaluation. At last, bagging algorithm is employed to calculate the overall performance of the model, i.e. theaverage
performP
ance across all sample model denoted as P ¼ 1 t ti ¼ 1 Pi where
Pi ð1  i  tÞ refers to the performance based on one sample set.
Furthermore, the sample space of each body fluid is divided into
training, validation and testing datasets according to the proportion
of 60%, 20% and 20%, respectively.

2.2 Neural network model
DeepSec takes protein sequences as input and performs a binary classification in terms of secretion into a specific body fluid or not.
Figure 2 summarizes the architecture of DeepSec, which comprises
three basic components: input sequences, feature extraction and
classification.
2.2.1 Input sequence generation
We first create a Position-Specific Score Matrix (PSSM) for each protein sequence to enable subsequent convolution operations. The protein sequence is embodied into a PSSM by position-specific iterative
basic local alignment search (PSI-BLAST) (Altschul et al., 1997)
against UniRef 90 (released in 2020_01) database with inclusion
0.001 and 3 iterations. For each protein with sequence length L, a
PSSM of dimensionality L  20 is obtained. The columns of PSSM
represent the presence of 20 amino acids in each position. We then
transform the PSSM described in Wang et al. (2016a) by the
Sigmoid function 1=ð1 þ expðxÞÞ where x represents a single entry
of the PSSM.
Since variable sequence length [from tens to thousands of amino
acids (aa) in this case] represents another challenge for building the
prediction model, we decide to use a fixed size (1000aa) window to
process protein sequences. It has been shown that N-terminus or Cterminus of the sequence carry the most useful signaling information. For instance, N-terminal modifications have a pivotal role in
protein regulation and cellular signaling (Varland et al., 2015), and
the identity of the C-terminal amino acids has a strong influence on
protein expression levels (Weber et al., 2020). Therefore, if a protein’s length exceeds 1000, we will keep 500 aa from N-terminus
and C-terminus, respectively, and remove the middle sequence. This
method of fixed size window has achieved remarkable performances
in protein localization prediction (Armenteros et al., 2017). In the
training dataset, 11.7% of the proteins are truncated using this rule.
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Fig. 2. The architecture of DeepSec which supports input as PSI-profiles based on protein sequences, feature extraction through CNN, classification based on BGRU with fully
connected dense layer, and the outputs as the probability of being secreted protein

If a protein sequence is <1000aa, the missing part is filled with 0. As
a result, the input representation of each protein is a matrix with size
[sequence length (L ¼ 1000)  size of amino acid vocabulary
(c ¼ 20)].
2.2.2 Feature extraction
To reveal hidden knowledge from the observed PSSM, a CNN model
is trained to extract a complex feature representation of the input sequence. Specifically, the input PSSM matrix is fed into CNN to learn
the weight parameters of the convolution filters. The filters are set to
calculate the feature map C. The convolution layer outputs the matrix inner product between the input matrix and the filters. The rectified linear unit (ReLU) was applied as the activation function to
sparsify the output of the convolution layer:
 X

X20
ðw1Þ=2
j
j
(1)
X

W
þ
b
Ci;j ¼ max 0;
iþd;c
dþðw1Þ=2;c
d¼ðw1Þ=2
c¼1
where X is the PSSM matrix, W j is jth the weight matrix of the convolution kernels, bj is the offset vector, Ci;j is the results of feature
extraction. Then, Ci;j is used as input to feed into the next layer.
2.2.3 Classification
For memorizing the residue presence in the C-terminus and N-terminus, respectively, we use the forwards and backwards GRU to
capture possible long-range dependencies between the sequence and
the prediction. Bidirectional GRU sweeps from both C-terminus to
N-terminus and N-terminus to C-terminus, and concatenates the
outputs of individual directions before feeding them into the fully
connected layer. The hidden states are updated recursively from the
convolutional features and the previous value of the hidden states
(Fig. 3).
The recurrent calculation at each sequence position t is
denoted as:
~t ; h t Þ
ht ¼ ðh

(2)

~
~t1 þ ~
~t ¼ ð1  ~
ztÞ  h
z t  h~ t
h

(3)

~t1 þ b~z Þ
~
z t ¼ rðW~z Ct þ U~z h

(4)



~
~t1 þ b~Þ
h~ t ¼ tanhðWh~Ct þ ~
r t  Uh~h
h

(5)

~t1 þ b~r Þ
~
r t ¼ rðW~r Ct þ U~r h

(6)

fcgLt ¼ 1

Fig. 3. The forwards and backwards GRU capturing possible long-range dependencies between the input sequence and the predicted class

~t . The tanh function is a
bias. The calculation of h t is similar to h
non-linear
activation
function
taking
the
form
of
tanhðxÞ ¼ 1þe22x  1.
Then, the subsequence classification is performed by a fully connected layer comprised hidden-layers and an output layer. The hidden layer computes a non-linear transformation, defined as follows:
f ¼ maxð0; ht  l þ  Þ

is
where l and  are the weight vector and bias respectively,
the learned hidden states of BGRU, ReLU activation is used.
Finally, the output layer computes the probability distribution ^y ,
defined as follow:
y^ ¼ rðf  c þ sÞ

fhgLt ¼ 1

is the input features of c at position t,
is the
where
hidden states of BGRU, where ht is a vector of 2-time size of the
number of hidden units in the individual direction GRU, W~z ,Wh~,
W~r , U~z , Uh~ and U~r are the weight metrics and b~z , bh~ and b~r are the

(7)
fhgLt ¼ 1

(8)

where c and s are the weight vector and the bias respectively,z and
j
the function r is the softmax function, denoted as rðzÞj ¼ PK e z ,
ek
k ¼ 1
for j ¼ 1; . . . ; K.
A cross-entropy loss function is used to quantify how ‘far away’
our prediction is from the ground truth. Network parameters are
optimized by minimizing the training errors. The backward pass
uses the chain rule to back-propagate error signals and computes
gradients with respect to all weights throughout the neural network.
Given a training set h ¼ fðv1 ; y1 Þ; . . . ; ðvn ; yn Þg, n is the number of
samples and y is the true output targets, the cross-entropy loss function is defined as:
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LðhÞ ¼

 
1 Xn X2
ðjÞ
ðjÞ
½y
log
y^i 
i
i¼1
j¼1
n

(9)

3.1 Model performance of DeepSec in 12 types of body
fluid

2.3 Performance assessment
The prediction performance is measured based on both training and
validation sets. Specifically, accuracy, Matthew’s correlation coefficient (MCC) and the Area under the ROC Curve (AUC) are applied.
Considering the unbalanced cases in this study, we also include additional measures including precision, recall and F-measure. Note that
higher values indicate better classification performance for all those
measures.
Accuracy represents how many predictions of the classifier are in
fact correct, defined as:
Accuracy ¼

TP þ TN
TP þ TN þ FP þ FN

(10)

where TP and TN are the true predictions in positives and negatives,
respectively, and FP and FN are the false predictions in positives and
negatives, respectively.
Recall (or sensitivity) shows how many positive examples are
correctly identified by the classifier. In this case, this is the percentage of secreted proteins identified as such, defined as:
Recall ¼

TP
TP þ FN

(11)

Precision represents the proportion of the correctly predicted
positive cases relative to all the predicted positive ones. In this case,
this is the percentage of proteins identified as secreted proteins that
actually secreted proteins, defined as:
Precision ¼

TP
TP þ FP

(12)

F-measure is the harmonic mean of precision and recall, and better reflects the performance of a classifier of unbalanced classes,
defined as:


precision  recall
(13)
F  measure ¼ 2 
precision þ recall
MCC is a correlation coefficient between the observed and predicted binary classifications, defined as:
ðTP  TN  FP  FNÞ
MCC ¼ pﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðTP þ FNÞðTP þ FPÞðTN þ FPÞðTN þ FNÞ

3 Results

(14)

2.4 Comparison with other models based on protein
features
Since SVM has been previously applied for secreted protein prediction, we first compare DeepSec with SVM models based on reported
protein features. In addition, two other state-of-the-art models,
including Decision Tree (DT) and Deep Neural Network (DNN),
are benchmarked together with DeepSec. To do this, we use the
same datasets to evaluate the performance to ensure a fairy comparison. We examine features used in the previous studies and also add a
few newly reported features, which can be grouped into four categories: (i) sequence properties; (ii) physicochemical properties; (iii)
domains/motifs properties; and (iv) structural properties. In total, a
total of 1610 protein features are collected (as detailed in
Supplementary Table S1). Then, feature selection is performed in a
similar workflow as documented in our previous publication
(Huang et al., 2021), where t-test (P value  0:005) and false discovery rate (FDR, q value  0:05) are employed to rank the features. The top 50 features are selected into the final model for 12
body fluids, respectively (Supplementary Table S2). Feature normalization is performed using Z-score method. Finally, these models are
evaluated in terms of accuracy, recall, precision, F-measure, MCC
and AUC.

All classification models on 12 body fluids were built and evaluated
using Pytorch 1.7.1, running python 3.8 and using Scikit-learn library
version 0.23.2. In DeepSec, the input representation of each protein is a
1000  20 matrix. Referring to Deeploc (Armenteros et al., 2017),
our model has 50 filters at the convolution layer with three different
sizes w¼f1; 5; 7g, which has led to a total of 150 filters and 1000 
150 feature maps. Next, GRU scanned the sequence using 32 hidden
units in each individual direction, leading to a total of 1000  64 outputs. The fully connected layer comprised a single hidden-layer with 16
units and an output layer with two units. The parameters were optimized by Adam optimizer with learning rate as 0.0001 and a dropout
probability as 0.1 prior to fully connected layer. We chose 0.5 as the
prediction threshold, which means that a probability 0:5 indicates a
positive class associated with secretion into a specific body fluid.
Finally, the performances on 12 body fluids were evaluated based on
testing dataset (Table 1) and all datasets (Table 2), respectively.
We have applied DeepSec to screen against all human proteins
(20 394 unique proteins) in the UniProtKB/Swiss-Prot database
(UniProt release 2020_06) in each of body fluids. As shown in
Figure 4, DeepSec predicted 12 364 proteins (60.6% of the 20 394)
as blood-secreted proteins, and 9491 (46.5%), 6877 (33.7%) and
6713 (32.9%) proteins to be secreted into urine, cerebrospinal fluid
and saliva, respectively.

3.2 DeepSec outperforms feature-based classifiers
We compared the performances between the DeepSec model and
aforementioned feature-based models based on average AUC on testing datasets. Here the feature-based DT model, SVM model and
DNN model are termed DTf, SVMf and DNNf, respectively. As
shown in Figure 5, for all 12 fluid types, DeepSec reported the best
performances with average AUC ranged in 0.85–0.94. Especially,
DeepSec was 4–17% higher than other models.

3.3 A close-look at the blood secreted protein prediction
In the blood protein case, the positive dataset consists of 8203 proteins while 2739 human proteins were generated in negative dataset.
Considering the count ratio (t) between positive and negative dataset
is round8203=2739 ¼ 3, we repeated 3 times the random sampling
processing and obtained 3 positive subsets. In the end, three datasets,
each containing 2734 positive samples and 2739 negative samples,
were used to train and evaluate DeepSec classifier.
To select the most appropriate model, we compared different
model architectures including CNN, BGRU and DeepSec. Each
model architecture was evaluated based on testing dataset and all
datasets in terms of accuracy, recall, precision, F-measure, MCC and
AUC (Table 3). The average ROCs are plotted in Figure 6. Note that
DeepSec classifier achieved the highest overall performance on both
testing dataset (average AUC: 0.94) and all datasets (average AUC:
0.94), respectively. In the meantime, it also attained the highest average values of accuracy (0.87/0.87), F-measure (0.91/0.87) and MCC
(0.69/0.74) on testing dataset and all datasets.
The results showed that the DeepSec model is more effective in
capturing sequence information for predicting secreted proteins and
reveals relationships between amino acid sequences and secretion
status. This is not surprising as BGRU is capable of learning longterm dependencies between sequence and secreted proteins, which
may contribute to an improved performance by updating the weight
of each hidden state.

4 An application case study on kidney cancer
biomarker discovery
To illustrate possible applications of DeepSec, we explored potential
kidney cancer biomarkers in blood by using public genomics data
and DeepSec prediction. To do that, we first collected gene

232

D.Shao et al.

Table 1. The performance evaluation on 12 body fluids based on testing dataset, grouped by several evaluation measures
Body fluids

Accuracy

Recall

Precision

F-measure

MCC

AUC

Blood
Saliva
Urine
Cerebrospinal fluid
Seminal fluid
Amniotic fluid
Tear fluid
Bronchoalveolar lavage fluid
Milk
Nipple aspirate fluid
Pleural effusion
Sputum

0.871139
0.824650
0.845857
0.835470
0.821891
0.828476
0.830080
0.859257
0.811124
0.816795
0.837814
0.823529

0.872120
0.810522
0.805017
0.667881
0.834073
0.747795
0.572529
0.432043
0.677016
0.565002
0.571637
0.822089

0.868200
0.835108
0.883817
0.931376
0.810378
0.889995
0.926077
0.966373
0.885655
0.956554
0.922045
0.824375

0.910294
0.797251
0.834207
0.747156
0.819841
0.790455
0.646611
0.551724
0.719173
0.687654
0.62887
0.775122

0.691481
0.643117
0.692125
0.637556
0.644204
0.649091
0.545096
0.502859
0.580265
0.594120
0.530781
0.633483

0.940572
0.898319
0.918341
0.900955
0.894597
0.905148
0.856645
0.857458
0.871808
0.887423
0.848811
0.891406

Note: The highest scores are in bold, and the lowest scores are underlined.

Table 2. The performance evaluation on 12 kinds of body fluids based on all datasets, grouped by different evaluation measures
Body fluids

Accuracy

Recall

Precision

F-measure

MCC

AUC

Blood
Saliva
Urine
Cerebrospinal fluid
Seminal fluid
Amniotic fluid
Tear fluid
Bronchoalveolar lavage fluid
Milk
Nipple aspirate fluid
Pleural effusion
Sputum

0.871345
0.769029
0.825711
0.819790
0.782139
0.806870
0.800349
0.832130
0.766363
0.787149
0.824978
0.781225

0.887427
0.666667
0.810127
0.700608
0.802020
0.839506
0.443730
0.364865
0.661253
0.592342
0.439560
0.759140

0.855263
0.844749
0.840196
0.887924
0.763359
0.781965
0.933014
0.949210
0.824742
0.895131
0.946759
0.794192

0.873381
0.710526
0.817456
0.738782
0.781496
0.790041
0.546535
0.465517
0.669014
0.664981
0.546697
0.719674

0.743075
0.522890
0.650832
0.603938
0.565294
0.616044
0.446769
0.395991
0.488595
0.520782
0.467328
0.543051

0.941104
0.855485
0.899171
0.869243
0.853547
0.893354
0.793570
0.792717
0.810696
0.837818
0.823116
0.849145

Note: The highest scores are in bold, and the lowest scores are underlined.

Fig. 4. Results of predicted human proteins secreted in 12 body fluids by screening against all human proteins reported in Swiss-Prot. The orange bar depicts number of predicted proteins against all human proteins in Swiss-Prot and blue bar depicts the experimental identified proteins

expression profiles of 72 paired kidney cancer tissues and adjacent
control tissues samples from kidney renal clear cell carcinoma
(KIRC) via the cancer genome atlas (TCGA) Data Portal. Each geneexpression dataset covered 19 804 human genes measured using

RNA-seq. Note the paired samples helps reduce the impact of individual variability in differential expression analysis.
Two-tailed t-test (Liang et al., 2019) was performed to identify
genes that have significant differential expression between kidney
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Fig. 5. The ROC curves for body-fluid protein prediction differentiation of DeepSec versus other models in 12 kinds of body fluids on testing datasets

Table 3. Prediction performance of various model architectures evaluated based on testing dataset and all datasets
Measures

Testing dataset

Accuracy
Recall
Precision
F-measure
MCC
AUC

All datasets

CNN

BGRU

DeepSec

CNN

BGRU

DeepSec

0.806068
0.782884
0.875502
0.858212
0.587026
0.912392

0.855145
0.911252
0.687112
0.904143
0.608209
0.897955

0.871139
0.872120
0.868200
0.910294
0.691481
0.940572

0.825292
0.777778
0.872807
0.816577
0.653542
0.906867

0.811404
0.931287
0.691520
0.831593
0.64152
0.903960

0.871345
0.887427
0.855263
0.873381
0.743075
0.941104

Note: The highest scores are in bold.

cancer and control samples. The test statistic tk for the kth feature
between case and control is given by
tk ¼ d k =sk

(15)

where d k and sk is the mean difference and the standard error of the
kth feature across n paired samples, denoted as
Xn
d k ¼ ð1=nÞ
d
(16)
i¼1 i;k
sk ¼

qX
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
n
2
di;k  d k =ðn  1Þ
i¼1

(17)

where di;k is the differential between the paired case and control for
the kth feature of the ith sample, given as

di;k ¼ Xi;1;k  Xi;2;k

(18)

logFC > 2 and adjusted P < 0:05 were used to identified differentially expressed genes between cancer group and normal control.
Overall, 138 and 261 genes (Supplementary Tables S3 and S4) were
found to be up- and down-regulated in kidney cancer versus control
tissues, respectively, hence making them as potential maker candidates in kidney cancer.
Based on all the differentially expressed genes (138 up-regulated
and 261 down-regulated) (Fig. 7) in kidney cancer versus control,
we applied DeepSec and further inferred that 261 of these biomarkers may be secreted into blood. Since 157 proteins have been
included in our positive dataset, the remaining 104 proteins are considered novel marker proteins identified by this prediction model.
Despite of the discordance between gene expression and protein
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Fig. 6. The ROC curves of various model architectures. (a) Evaluation on testing dataset. (b) Evaluation on all datasets

secretory proteins. Indeed, with larger number of positive instances
being identified by wet lab experiments, this model can be better
tuned, as demonstrated in Cui et al. (2008). Second, since the protein
sequences are compressed into a fixed size vector, there is a risk of
information loss. Note that 11.7% (1990 proteins) of human proteins have been influenced by the truncation rule. However, when
analyzing the physical properties of those proteins, we understand
that the probability of the secreted proteins having long anomic acid
sequences is very low, which implies a minimal negative impact on
the DeepSec’s performance if there is any. Last, since we addressed
the imbalance problem by sampling multiple smaller subsets and
recalculates the probabilities based on the same small dataset during
the training process, there is a certain likelihood that it introduces
risks of overfitting while yielding significantly improved performance. However, when evaluating the performance of DeepSec on all
datasets (Table 2), it appears confidently that DeepSec doesn’t overly
fit the data.

Fig. 7. The significant differential expression between kidney cancer and control
samples, including up- and down-regulated results

abundance, proteins that show significantly elevated gene expression
in kidney cancer tissues versus control can be more promising marker candidates compared to those repressed ones. The detailed prediction results about up- and down-regulated protein markers of kidney
cancer in blood are listed in Supplementary Table S5.

5 Discussion
DeepSec represents the first generalized computational model that can
predict secreted proteins in multiple human body fluids. Specifically,
this end-to-end model is built based on sequence features extracted via
CNN followed by bidirectional GRU. Compared to other models based
on proteins features, DeepSec has demonstrated improved prediction
accuracy and better generalizability (Fig. 5), which indicates the advantage of sequence-based method as compared to feature-based algorithms. In the blood protein case, the model shows reasonably high
AUC (0.94/0.94) and high F-measure (0.91/0.87) on testing dataset and
all datasets, as compared to other model architectures (Table 3), which
also suggests that DeepSec has good representation of the relevant proteins across the whole protein space.
However, there might be some concerns about the limitations of
DeepSec. First, due to the lack of clear knowledge about non-bodyfluid secretory proteins, this study generates negative dataset based
on Pfam family information. It means that the negative datasets may
not adequately include the whole space of the non-body-fluid

6 Conclusion
In summary, we propose a DL method, DeepSec, to predict secreted
proteins in 12 kinds of human body fluids based on protein sequences.
To the best of our knowledge, DeepSec is the first system that fully capture the sequence features related to protein secretion automatically
using CNN with BGRU architecture. The BGRU network is able to
capture possible long-range dependencies between sequence and
secreted status of proteins, which contributes to the improved performance. DeepSec is able to predict the secreted protein with higher accuracy than existing state-of-the-art methods. Moreover, DeepSec is useful
for discovering novel candidates of blood biomarkers in kidney cancer
that have been experimentally verified. Our future effort will focus on
including more types of human body fluids into the system and improve
the performance toward biomarker discovery in complex human diseases and physiological phenotypes.
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